|
Saura D, Marín F, Climent V, González J, Roldán V, Hernández-Romero D, Oliva MJ, Sabater M, de la Morena G, Lip GY, Valdés M. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling. Int J Clin Pract. 2009 Oct;63(10):1465-71. doi: 10.1111/j.1742-1241.2009.02127.x. PubMed PMID: 19769703.
AÑO: 2009; IF: 2.245
|
19769703
|
Pérez-Andreu V, Roldán V, González-Conejero R, Hernández-Romero D, Vicente V, Marín F. Implications of pharmacogenetics for oral anticoagulants metabolism. Curr Drug Metab. 2009 Jul;10(6):632-42. PubMed PMID: 19799531.
AÑO: 2009; IF: 3.989
|
|
Gimeno JR, Monserrat L, Pérez-Sánchez I, Marín F, Caballero L, Hermida-Prieto M, Castro A, Valdés M. Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families. Rev Esp Cardiol. 2009 Dec;62(12):1473-7. PubMed PMID: 20038417.
AÑO: 2009; IF: 2.746
|
|
Tello-Montoliu A, Marín F, Roldán V, Lip GY. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Heart. 2010 Feb;96(3):227-8; author reply 228. doi: 10.1136/hrt.2009.182105. PubMed PMID: 20133421.
AÑO: 2010; IF: 4.708
|
|
López-Cuenca A, Roldán V, Marín F. Hypouricemic effect of statins: another pleiotropic benefit? J Thorac Cardiovasc Surg. 2010 May;139(5):1358-9. doi: 10.1016/j.jtcvs.2009.08.063. PubMed PMID: 20412974.
AÑO: 2010; IF: 3.608
|